EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 27 / No 5 (Mai 2011) Med Sci (Paris), 27 5 (2011) 471-472 References
Free Access
Issue
Med Sci (Paris)
Volume 27, Number 5, Mai 2011
Page(s) 471 - 472
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2011275008
Published online 25 May 2011
  1. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008 ; 9 : 239-244. [CrossRef] [PubMed] [Google Scholar]
  2. Salomon BL. Les lymphocytes T régulateurs CD4+CD25+: vers une immuno-modulation thérapeutique ?. Med Sci (Paris) 2002 ; 18 : 1066-1068. [CrossRef] [EDP Sciences] [Google Scholar]
  3. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001 ; 27 : 18-20. [CrossRef] [PubMed] [Google Scholar]
  4. Salomon B, Lenschow DJ, Rhree L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 ; 12 : 431-440. [CrossRef] [PubMed] [Google Scholar]
  5. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004 ; 199 : 1455-1465. [CrossRef] [PubMed] [Google Scholar]
  6. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993 ; 75 : 253-261. [CrossRef] [PubMed] [Google Scholar]
  7. Tang Q, Adams JY, Penaranda C, et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008 ; 28 : 687-697. [CrossRef] [PubMed] [Google Scholar]
  8. Grinberg-Bleyer Y, Baeyens A, You S, et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med 2010 ; 207 : 1871-1878. [CrossRef] [PubMed] [Google Scholar]
  9. Grinberg-Bleyer Y, Saadoun D, Baeyens A, et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2010 ; 120 : 4558-4568. [CrossRef] [PubMed] [Google Scholar]
  10. TNF neutralization in MS : results of a randomized, placebo-controlled multicenter study. The Lenercept multiple sclerosis study group and the University of British Columbia MS/MRI analysis group. Neurology 1999 ; 53 : 457-465. [CrossRef] [PubMed] [Google Scholar]
  11. Liu J, Marino MW, Wong G, et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998 ; 4 : 78-83. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.